Ann F. Cheung

Person

Lincoln, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Multi-specific binding proteins that bind CD33, NKG2D, and CD16, an...
- Patent number 12,215,157
- Issue date Feb 4, 2025
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Proteins binding NKG2D, CD16 and CLEC12A
- Patent number 12,157,771
- Issue date Dec 3, 2024
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody variable domains targeting the NKG2D receptor
- Patent number 12,129,300
- Issue date Oct 29, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody variable domains targeting the NKG2D receptor
- Patent number 11,939,384
- Issue date Mar 26, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody variable domains targeting the NKG2D receptor
- Patent number 11,884,733
- Issue date Jan 30, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Proteins binding HER2, NKG2D and CD16
- Patent number 11,884,732
- Issue date Jan 30, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multi-specific binding proteins that bind NKG2D, CD16, and a tumor-...
- Patent number 11,834,506
- Issue date Dec 5, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric Fc-fused proteins
- Patent number 11,787,864
- Issue date Oct 17, 2023
- Dragonfly Therapeutics, Inc.
- Ann F. Cheung
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20250019444
- Publication date Jan 16, 2025
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND BAFF-R
- Publication number 20240360223
- Publication date Oct 31, 2024
- Dragonfly Therapeutics, Inc.
- Aaron BELLI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND BAFF-R
- Publication number 20240270861
- Publication date Aug 15, 2024
- Dragonfly Therapeutics, Inc.
- Aaron BELLI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING HER2, NKG2D AND CD16
- Publication number 20240228625
- Publication date Jul 11, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TARGETING FLT3 AND USE THEREOF
- Publication number 20240228628
- Publication date Jul 11, 2024
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND NKG2D, CD16, AND A TUMOR-...
- Publication number 20240166753
- Publication date May 23, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TARGETING FLT3 AND USE THEREOF
- Publication number 20240132598
- Publication date Apr 25, 2024
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16, AND CEACAM5
- Publication number 20240124607
- Publication date Apr 18, 2024
- Merck Sharp & Dohme LLC
- Amy M. Beebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND FLT3
- Publication number 20240117054
- Publication date Apr 11, 2024
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20240076385
- Publication date Mar 7, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20240076384
- Publication date Mar 7, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20240067735
- Publication date Feb 29, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEINS BINDING CD123, NKG2D AND CD16
- Publication number 20240018266
- Publication date Jan 18, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC BINDING PROTEINS TARGETING CEA
- Publication number 20230391877
- Publication date Dec 7, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND NECTIN4
- Publication number 20230357409
- Publication date Nov 9, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...
- Publication number 20230303702
- Publication date Sep 28, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Formulation, Dosage Regimen, and Manufacturing Process for Heterodi...
- Publication number 20230272041
- Publication date Aug 31, 2023
- Dragonfly Therapeutics, Inc.
- Mitchell Bigelow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND EGFR
- Publication number 20230257467
- Publication date Aug 17, 2023
- Dragonfly Therapeutics, Inc.
- Ann F. Cheung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PPHARMACEUTICAL FORMULATIONS AND THERAPEUTIC USES OF MULTI-SPECIFIC...
- Publication number 20230250176
- Publication date Aug 10, 2023
- Dragonfly Therapeutics, Inc.
- Ann F. Cheung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...
- Publication number 20230227562
- Publication date Jul 20, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Targeting CLEC12A and Use Thereof
- Publication number 20230220084
- Publication date Jul 13, 2023
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETERODIMERIC FC-FUSED PROTEINS
- Publication number 20230033425
- Publication date Feb 2, 2023
- Dragonfly Therapeutics, Inc.
- Ann F. Cheung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AN...
- Publication number 20220380459
- Publication date Dec 1, 2022
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL FORMULATIONS AND DOSAGE REGIMENS FOR MULTI-SPECIFIC...
- Publication number 20220195065
- Publication date Jun 23, 2022
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN
- Publication number 20220153848
- Publication date May 19, 2022
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND CLEC12A
- Publication number 20220119534
- Publication date Apr 21, 2022
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC FC-FUSED PROTEINS
- Publication number 20220119533
- Publication date Apr 21, 2022
- Dragonfly Therapeutics, Inc.
- Ann F. CHEUNG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND...
- Publication number 20220089760
- Publication date Mar 24, 2022
- Dragonfly Therapeutics, Inc.
- Mitchell Bigelow
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING DLL3, AND USE THEREOF
- Publication number 20220025037
- Publication date Jan 27, 2022
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEIN BINDING NKG2D, CD16 AND A FIBROBLAST ACTIVATION PROTEIN
- Publication number 20210363261
- Publication date Nov 25, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY

Ann F. Cheung

Person

Patents Grantslast 30 patents

Multi-specific binding proteins that bind CD33, NKG2D, and CD16, an...

Proteins binding NKG2D, CD16 and CLEC12A

Antibody variable domains targeting the NKG2D receptor

Antibody variable domains targeting the NKG2D receptor

Antibody variable domains targeting the NKG2D receptor

Proteins binding HER2, NKG2D and CD16

Multi-specific binding proteins that bind NKG2D, CD16, and a tumor-...

Heterodimeric Fc-fused proteins

Patents Applicationslast 30 patents

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

PROTEINS BINDING NKG2D, CD16 AND BAFF-R

PROTEINS BINDING NKG2D, CD16 AND BAFF-R

PROTEINS BINDING HER2, NKG2D AND CD16

ANTIBODIES TARGETING FLT3 AND USE THEREOF

MULTI-SPECIFIC BINDING PROTEINS THAT BIND NKG2D, CD16, AND A TUMOR-...

ANTIBODIES TARGETING FLT3 AND USE THEREOF

PROTEINS BINDING NKG2D, CD16, AND CEACAM5

PROTEINS BINDING NKG2D, CD16 AND FLT3

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

PROTEINS BINDING CD123, NKG2D AND CD16

MULTISPECIFIC BINDING PROTEINS TARGETING CEA

PROTEINS BINDING NKG2D, CD16 AND NECTIN4

COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...

Formulation, Dosage Regimen, and Manufacturing Process for Heterodi...

PROTEINS BINDING NKG2D, CD16 AND EGFR

PPHARMACEUTICAL FORMULATIONS AND THERAPEUTIC USES OF MULTI-SPECIFIC...

COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...

Antibodies Targeting CLEC12A and Use Thereof

HETERODIMERIC FC-FUSED PROTEINS

MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AN...

PHARMACEUTICAL FORMULATIONS AND DOSAGE REGIMENS FOR MULTI-SPECIFIC...

PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN

PROTEINS BINDING NKG2D, CD16 AND CLEC12A

HETERODIMERIC FC-FUSED PROTEINS

MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND...

ANTIBODY VARIABLE DOMAINS TARGETING DLL3, AND USE THEREOF

PROTEIN BINDING NKG2D, CD16 AND A FIBROBLAST ACTIVATION PROTEIN